Eikon Therapeutics Common Stock Accounts Payable

Eikon Therapeutics Common Stock (EIKN) currently reports a accounts payable of $6M as of March 2026. Use the charts on this page to explore Eikon Therapeutics Common Stock's accounts payable history and peer comparisons.

Eikon Therapeutics Common Stock reported $6M in accounts payable as of March 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $6M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Eikon Therapeutics Common Stock, and consider following EIKN for alerts when major investors trade the stock.

Eikon Therapeutics Common Stock is classified in the Healthcare sector. On accounts payable, it currently shows $6M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EIKN with unrelated industries.